Search Site

Trends banner

TomTom cuts 300 jobs

The firm said it was realigning its organization as it embraces AI.

Aldar nets $953m in sales at Fahid

Aldar said 42 percent of the buyers are under the age of 45.

Qualcomm to Alphawave for $2.4 bn

The deal makes Alphawave the latest tech company to depart London.

Equinor signs $27 bn gas deal

The 10-year contract was signed with Centrica.

ADNOC Drilling secures $1.15bn contract

The contract for two jack-up rigs begins in the second quarter.

Saudi Arabia to invest $3bn in vaccines, vital medicines industry

Saudi Arabia to invest $3bn in vaccines, vital medicines industry. AFP/File
  • Saudi Minister Bandar bin Ibrahim Alkhorayef said that the targeted pharmaceutical sectors whose value exceeds US$5 billion will be implemented in several stages
  • The second phase, the minster said, will focus on localising immunological and cancer treatments technologies

Saudi Arabia announced on Friday the launch of several investment opportunities in the vaccines and vital medicines industry, valued at US$3.4 billion, to achieve pharmaceutical and health security, and making Saudi Arabia an important center for this promising industry.

According to the Saudi Press Agency, Saudi Minister of Industry and Mineral Resources and Chairman of the Manufacturing Vaccines and Vital Medicines Committee Bandar bin Ibrahim Alkhorayef said that the targeted pharmaceutical sectors in general, whose value exceeds US$5 billion, will be implemented in several stages, starting with vaccines and vital medicines. He added that the focus will be on localising vaccines, plasma, and insulin technologies. 

The second phase, the minster said, will focus on localising immunological and cancer treatments technologies, where the size of this vital sector is estimated at more than US$2 billion annually, of which insulin represents approximately US$340 million.